These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 337087)

  • 1. [Clenbuterol: review of a new broncholytic agent].
    Rensch H; Renovanz HD
    Med Monatsschr; 1977 Oct; 31(10):457-60. PubMed ID: 337087
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of clenbuterol on pulmonary circulation and on oxygen delivery in chronic airflow obstruction.
    Bertoli L; Graziina A; Lo Cicero S; Motelli R; Schiassi M
    Eur J Respir Dis Suppl; 1986; 146():503-10. PubMed ID: 3465576
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.
    Tschan M; Perruchoud A; Herzog H
    Eur J Clin Pharmacol; 1979 Apr; 15(3):159-62. PubMed ID: 378670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of 3 beta-mimetic bronchodilators: clenbuterol, hexoprenaline, fenoterol. Comparative study].
    Villate Navarro JI; Sobradillo Peña V; Atxotegui Iraola-Goitia V; Uresandi Romero F; Sánchez García J
    Rev Clin Esp; 1980 Sep; 158(5):215-8. PubMed ID: 7001578
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of clenbuterol on bronchial, cardiac and hypothalamic adenylate cyclase.
    Marmo E; Caputi AP; Nisticò GM; Rossi F; Lampa E
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):3-9. PubMed ID: 441515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardio-circulatory effects of a new beta-adrenergic agent: clenbuterol].
    Pasotti C; Gandolfi P
    Boll Soc Ital Cardiol; 1981; 26(9):873-5. PubMed ID: 7347270
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of clenbuterol on mucociliary transport in healthy horses and horses with chronic obstructive pulmonary disease.
    Turgut K; Sasse HH
    Vet Rec; 1989 Nov; 125(21):526-30. PubMed ID: 2595990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of the alveolar-arterial oxygen gradients and intrapulmonary shunt under the action of NAB-365, a new exogenous catecholamine of selective beta-2 action (author's transl)].
    Montero Benzo R; Salas Font A
    Med Clin (Barc); 1979 Jan; 72(1):24-8. PubMed ID: 372694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bronchodilator and bronchial hyperreactivity-inhibiting effects of clenbuterol in patients with bronchial asthma].
    Chazan R; Kokot M; Droszcz W
    Pneumonol Pol; 1986 Oct; 54(10):437-42. PubMed ID: 2883628
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clenbuterol: a new partial antagonist of the beta adrenergic receptors (author's transl)].
    Morales-Olivas FJ; Brugger AJ; Bedate H; García-Díez JM; Morcillo E; Esplugues J
    Arch Farmacol Toxicol; 1980 Aug; 6(2):131-8. PubMed ID: 6110409
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of clenbuterol hydrochloride on the pulmonary function of calves with subacute and chronic bronchopneumonia.
    Hajer R
    Vet Rec; 1988 Oct; 123(14):370-2. PubMed ID: 3195027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.
    Baronti A; Griceo A; Vibelli C
    Eur J Clin Pharmacol; 1978 May; 13(3):171-7. PubMed ID: 352703
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a tocolytic agent on the farrowing of sows].
    Collins K; Hardebeck H; Sommer H
    Berl Munch Tierarztl Wochenschr; 1980 Aug; 93(16):310-2. PubMed ID: 6110420
    [No Abstract]   [Full Text] [Related]  

  • 17. Uterine relaxation by clenbuterol and fenoterol in conscious rats.
    Streller I
    Arzneimittelforschung; 1985; 35(1A):315-8. PubMed ID: 4039171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological effects of acute and chronic clenbuterol treatments after lesions of central noradrenergic nerve terminals.
    Francès H; Struck I; Simon P; Raisman R
    J Pharmacol; 1986; 17(4):547-52. PubMed ID: 3560967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of clenbuterol on electroacupuncture analgesia and morphine analgesia in rats].
    Su SY; Zheng SQ; Lu YY
    Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):82-4. PubMed ID: 6087614
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies on the oral therapy of obstructive respiratory tract diseases with clenbuterol, fenoterol and depot-orciprenaline (double-blind study)].
    Flohr E; Bischoff KO
    Verh Dtsch Ges Inn Med; 1978; (84):417-20. PubMed ID: 369198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.